Related Experiment Video
Updated: Jul 18, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended
Allan J Collins1, James P Ebben, David T Gilbertson
1Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN, USA. acollins@cdrg.org
Summary
Dialysis providers vary in their management of recombinant human erythropoietin (rHuEPO) doses for patients with high hemoglobin levels. Practices differ significantly between providers and facility types, impacting dose adjustments.
Area of Science:
- Nephrology
- Healthcare Management
- Pharmacoeconomics
Background:
- Investigates provider practices for recombinant human erythropoietin (rHuEPO) dosing in hemodialysis patients.
- Focuses on hemoglobin levels exceeding 13 g/dL (130 g/L).
Purpose of the Study:
- To analyze variations in rHuEPO dose management among different dialysis providers.
- To identify factors influencing dose reduction practices when hemoglobin targets are surpassed.
Main Methods:
- Retrospective analysis of 167,796 hemodialysis patients from January 1, 2003.
- Utilized Centers for Medicare & Medicaid Services (CMS) data for patient characteristics and claims.
- Employed logistic regression to assess provider effects on dose adjustments.
Main Results:
- DaVita showed the highest percentage of claims (16.7%) and mean rHuEPO dose (54,299 units) for high hemoglobin levels.
- Dialysis Clinic Inc. had the lowest percentage of claims (2.0%) and mean dose (38,687 units).
- Independent and non-hospital-based providers (Dialysis Clinic Inc, Fresenius, Renal Care Group) were more likely to adjust rHuEPO doses compared to DaVita and hospital-based units.
Conclusions:
- Recombinant human erythropoietin (rHuEPO) dose reduction practices are provider-dependent.
- Facility type (hospital-based vs. independent) significantly influences rHuEPO dosing strategies.
Related Concept Videos
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:25Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
01:25Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...